Skip to content
  • Sunday, 26 July 2026
  • 3:41 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Takeda Ordered to Pay $885 Million in Landmark "Pay-for-Delay" Drug Case, Faces Potential $2.5 Billion Liability
Pharmaceutical R&D

Takeda Ordered to Pay $885 Million in Landmark "Pay-for-Delay" Drug Case, Faces Potential $2.5 Billion Liability

Teuku Ryan May 21, 2026 0

In a groundbreaking verdict that could reshape pharmaceutical antitrust litigation, a U.S. jury has found Japanese pharmaceutical giant Takeda liable…

Read More
Pharmaceutical R&D

Regeneron Pharmaceuticals and Parabilis Medicines Forge Landmark $2.32 Billion Collaboration to Pioneer a New Era of Intracellular Therapies

Teuku Ryan May 20, 2026 0

Regeneron Pharmaceuticals has announced a monumental research collaboration with Parabilis Medicines, a deal valued at an impressive $2.32 billion. This…

Read More
Neuroscience & Brain Research

Evolutionary Origins of Human Handedness Linked to Bipedalism and Brain Expansion in Landmark Oxford Study

Rifan Muazin May 18, 2026 0

The mystery of why the vast majority of the human population favors the right hand has remained one of the…

Read More
Stem Cell & Regenerative Medicine

Explosive Growth and Early Origins of Chronic Myeloid Leukemia Revealed in Landmark Genomic Study

Dwi Wanna May 18, 2026 0

A pioneering research project led by the Wellcome Sanger Institute has fundamentally altered the scientific understanding of chronic myeloid leukemia…

Read More
Pharmaceutical R&D

Tirzepatide Confirmed as Best-in-Class Obesity Therapy Following Landmark SURMOUNT-MAINTAIN Trial Results

Teuku Ryan May 17, 2026 0

Findings from the pivotal Phase III SURMOUNT-MAINTAIN trial, presented at the 33rd European Congress on Obesity (ECO) in Istanbul, Türkiye,…

Read More
Neuroscience & Brain Research

McGill University Researchers Identify Specific Brain Cell Disruptions Linked to Major Depressive Disorder in Landmark Study

Rifan Muazin May 15, 2026 0

A groundbreaking study led by researchers at McGill University and the Douglas Research Centre has unveiled specific cellular abnormalities in…

Read More
Pharmaceutical R&D

EU Strikes Landmark Deal on Critical Medicines Act to Fortify Pharmaceutical Sector and Ensure Patient Supply

Teuku Ryan May 13, 2026 0

The European Union (EU) has achieved a significant legislative milestone with the provisional agreement on the Critical Medicines Act (CMA),…

Read More
Pharmaceutical R&D

Bristol Myers Squibb and Hengrui Pharma Forge Landmark $15.2 Billion Oncology and Immunology Collaboration

Teuku Ryan May 13, 2026 0

Bristol Myers Squibb (BMS) and Chinese biopharmaceutical giant Hengrui Pharma have announced a monumental licensing and collaboration agreement, potentially valued…

Read More
Pharmaceutical R&D

FDA Issues Landmark Guidance to Enhance Pregnancy Safety Data for Medications

Teuku Ryan May 12, 2026 0

The US Food and Drug Administration (FDA) has unveiled its comprehensive final guidance for industry on collecting crucial post-marketing safety…

Read More
Advanced Materials Science

Physicists Achieve Landmark Experimental Proof of Kardar-Parisi-Zhang Universality in Two-Dimensional Quantum Systems

Nila Kartika Wati May 7, 2026 0

The field of statistical physics has reached a transformative milestone as researchers at the University of Würzburg, in collaboration with…

Read More

Posts pagination

1 2 3 4 … 6
Parabilis Medicines Aims for $475 Million Nasdaq IPO to Fund Pivotal Desmoid Tumour Trial and Pipeline ExpansionImperial College London Researchers Achieve Breakthrough in Quantum Sensing for Dark Matter and Gravitational Wave DetectionScience News: Empowering Public Understanding of Science, Medicine, and Technology Since 1921Unifying Genetic Pathways: Shared Genes Hold Promise for Future Human Limb Regeneration
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ